Holly B. Kordasiewicz sold $313K of Ionis Pharmaceuticals (IONS)

Executed Jan 16, disclosed Jan 20, 4 days later.

Value, as filed

$313K

4,141 sh × $75.66

Executed

Jan 16

the trade date, as filed

Disclosed

Jan 20

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

HK Holly B. Kordasiewicz EVP, Chief Development Officer profile →

Holly B. Kordasiewicz (EVP, Chief Development Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $4.5M of IONS (60,846 sh across 2 lots, as filed), executed Jun 12.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Holly B. Kordasiewicz in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $4.5M
60,846 sh across 2 lots
Exec Jun 12
Filed Jun 16 · 5:30 PM ET